How big is the Tremfya market?

The global Tremfya market size was estimated at USD 3.67 billion in 2024 and is expected to reach USD 4.06 billion in 2025.

What is the Tremfya market growth?

The global Tremfya market is projected to grow at a CAGR of 7.60% from 2025 to 2033 to reach USD 7.29 billion by 2033.

Which segment accounted for the largest Tremfya market share?

Based on application, plaque psoriasis segment dominated the market with the largest revenue share of 87.0% in 2024, driven by the increasing prevalence of moderate-to-severe cases and growing demand for targeted biologic therapies.

Who are the key players in the Tremfya market?

Johnson & Johnson Services, Inc. remains the key player in the Tremfya market, leveraging its strong global presence, robust regulatory approvals, and comprehensive distribution networks. Strategic pricing, innovative research, and effective supply chain operations influence competitive dynamics in this market.

What are the factors driving the Tremfya market?

Tremfya’s market growth is driven by rising autoimmune disease prevalence, strong clinical efficacy in psoriasis and psoriatic arthritis, and expanding indications like ulcerative colitis. Its targeted IL-23 inhibition, favorable safety profile, and convenient subcutaneous dosing support high patient adherence and growing acceptance among dermatologists and rheumatologists.